These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 25031389)

  • 1. Gene of the month: Interleukin 6 (IL-6).
    Ataie-Kachoie P; Pourgholami MH; Richardson DR; Morris DL
    J Clin Pathol; 2014 Nov; 67(11):932-7. PubMed ID: 25031389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-6 and related cytokines as the critical lynchpins between inflammation and cancer.
    Taniguchi K; Karin M
    Semin Immunol; 2014 Feb; 26(1):54-74. PubMed ID: 24552665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-6: A Masterplayer in the Cytokine Network.
    Uciechowski P; Dempke WCM
    Oncology; 2020; 98(3):131-137. PubMed ID: 31958792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-6, A Cytokine Critical to Mediation of Inflammation, Autoimmunity and Allograft Rejection: Therapeutic Implications of IL-6 Receptor Blockade.
    Jordan SC; Choi J; Kim I; Wu G; Toyoda M; Shin B; Vo A
    Transplantation; 2017 Jan; 101(1):32-44. PubMed ID: 27547870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting interleukin-6 in inflammatory autoimmune diseases and cancers.
    Yao X; Huang J; Zhong H; Shen N; Faggioni R; Fung M; Yao Y
    Pharmacol Ther; 2014 Feb; 141(2):125-39. PubMed ID: 24076269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-6 and its receptor in cancer: implications for translational therapeutics.
    Hong DS; Angelo LS; Kurzrock R
    Cancer; 2007 Nov; 110(9):1911-28. PubMed ID: 17849470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biological effects of interleukin-6: Clinical applications in autoimmune diseases and cancers.
    Ho LJ; Luo SF; Lai JH
    Biochem Pharmacol; 2015 Sep; 97(1):16-26. PubMed ID: 26080005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new era for the treatment of inflammatory autoimmune diseases by interleukin-6 blockade strategy.
    Tanaka T; Narazaki M; Ogata A; Kishimoto T
    Semin Immunol; 2014 Feb; 26(1):88-96. PubMed ID: 24594001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of the IL-6 signaling pathway: a strategy to combat chronic inflammatory diseases and cancer.
    Ataie-Kachoie P; Pourgholami MH; Morris DL
    Cytokine Growth Factor Rev; 2013 Apr; 24(2):163-73. PubMed ID: 23107589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-6 biology is coordinated by membrane-bound and soluble receptors: role in inflammation and cancer.
    Rose-John S; Scheller J; Elson G; Jones SA
    J Leukoc Biol; 2006 Aug; 80(2):227-36. PubMed ID: 16707558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-6 as a therapeutic target in candidate inflammatory diseases.
    Nishimoto N
    Clin Pharmacol Ther; 2010 Apr; 87(4):483-7. PubMed ID: 20182422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New insights for IL-6 targeted therapy as an adjuvant treatment for non-small-cell lung cancer.
    Zarogoulidis P; Yarmus L; Zarogoulidis K
    Ther Deliv; 2013 Oct; 4(10):1221-3. PubMed ID: 24116905
    [No Abstract]   [Full Text] [Related]  

  • 13. The soluble Interleukin 6 receptor: generation and role in inflammation and cancer.
    Chalaris A; Garbers C; Rabe B; Rose-John S; Scheller J
    Eur J Cell Biol; 2011; 90(6-7):484-94. PubMed ID: 21145125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Interleukin-6 From molecular mechanisms of signal transduction to physiological properties and therapeutic targeting].
    Drutskaya MS; Nosenko MA; Atretkhany KS; Efimov GA; Nedospasov SA
    Mol Biol (Mosk); 2015; 49(6):937-43. PubMed ID: 26710772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-6: discovery of a pleiotropic cytokine.
    Kishimoto T
    Arthritis Res Ther; 2006; 8 Suppl 2(Suppl 2):S2. PubMed ID: 16899106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factor Xa Signaling Contributes to the Pathogenesis of Inflammatory Diseases.
    Ebrahimi S; Rezaei S; Seiri P; Ryzhikov M; Hashemy SI; Hassanian SM
    J Cell Physiol; 2017 Aug; 232(8):1966-1970. PubMed ID: 27925197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammatory cytokines in human pancreatic cancer.
    Roshani R; McCarthy F; Hagemann T
    Cancer Lett; 2014 Apr; 345(2):157-63. PubMed ID: 23879960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigation of sanguinarine and chelerythrine effects on LPS-induced inflammatory gene expression in THP-1 cell line.
    Pěnčíková K; Kollár P; Müller Závalová V; Táborská E; Urbanová J; Hošek J
    Phytomedicine; 2012 Jul; 19(10):890-5. PubMed ID: 22592163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Versatile functions for IL-6 in metabolism and cancer.
    Mauer J; Denson JL; Brüning JC
    Trends Immunol; 2015 Feb; 36(2):92-101. PubMed ID: 25616716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-6/IL-6 receptor system and its role in physiological and pathological conditions.
    Mihara M; Hashizume M; Yoshida H; Suzuki M; Shiina M
    Clin Sci (Lond); 2012 Feb; 122(4):143-59. PubMed ID: 22029668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.